Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.46 |
| ▸ | FNTB | P49356 | 1/20 | 0.46 |
| ▸ | SQLE | Q14534 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14236826 | 1.00 | KDM1A (0.53) | KDM1AALOX15ALDH1A1PTPN1FNTA | |
| SCHEMBL11551085 | 1.00 | KDM1A (0.53) | KDM1AALOX15ALDH1A1PTPN1FNTA | |
| SCHEMBL14236910 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236839 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236868 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236787 | 0.98 | KDM1A (0.51) | KDM1AALOX15ALDH1A1PTPN1FNTA | |
| SCHEMBL14236905 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236830 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236805 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB | |
| SCHEMBL14236904 | 0.98 | KDM1A (0.55) | KDM1AALOX15ALDH1A1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4288404-A1 | ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP Assets B.V. (NL) | 2023-12-13 | — | — | EP | claimed |
| CN-116829528-A | Organic tertiary or quaternary ammonium salts as catalysts in the formation of gamma, delta-unsaturated ketones | 帝斯曼知识产权资产管理有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-114907195-A | Using tertiary amines with SO 3 Preparation of unsaturated ketones | 帝斯曼知识产权资产管理有限公司 | 2022-08-16 | — | — | CN | claimed |
| WO-2022167643-A1 | ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP ASSETS B.V. (NL) | 2022-08-11 | — | — | WO | claimed |
| EP-1179520-A1 | Process for the preparation of phytone and novel intermediates thereof | AVENTIS ANIMAL NUTRITION S.A. (FR) | 2002-02-13 | — | — | EP | claimed |
| EP-4288404-A1 | ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP Assets B.V. (NL) | 2023-12-13 | — | — | EP | disclosed |
| CN-116829528-A | Organic tertiary or quaternary ammonium salts as catalysts in the formation of gamma, delta-unsaturated ketones | 帝斯曼知识产权资产管理有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-114907195-A | Using tertiary amines with SO 3 Preparation of unsaturated ketones | 帝斯曼知识产权资产管理有限公司 | 2022-08-16 | — | — | CN | disclosed |
| WO-2022167643-A1 | ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP ASSETS B.V. (NL) | 2022-08-11 | — | — | WO | disclosed |
| US-9981935-B2 | Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of acids | DSM IP ASSETS B.V. (NL) | 2018-05-29 | — | — | US | disclosed |
| US-9815809-B2 | Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of phenols or thiophenols | DSM IP ASSETS B.V. (NL) | 2017-11-14 | — | — | US | disclosed |
| US-9809565-B2 | Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of ureas or thioureas | DSM IP ASSETS B.V. (NL) | 2017-11-07 | — | — | US | disclosed |
| WO-2015001029-A1 | FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS | DSM IP ASSETS B.V. (NL) | 2015-01-08 | — | — | WO | disclosed |
| WO-2015001031-A1 | FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES | DSM IP ASSETS B.V. (NL) | 2015-01-08 | — | — | WO | disclosed |
| US-20140249321-A1 | HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE y, -POSITION | DSM IP ASSETS B.V. (NL) | 2014-09-04 | — | — | US | disclosed |
| EP-2720996-A1 | HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE , -POSITION | DSM IP Assets B.V. (NL) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012171969-A1 | HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE γ, δ-POSITION | DSM IP ASSETS B.V. (NL) | 2012-12-20 | — | — | WO | disclosed |
| EP-2535323-A1 | Hydrogenation of ketones having at least a carbon-carbon double bond in the gamma-,delta-position | DSM IP Assets B.V. (NL) | 2012-12-19 | — | — | EP | disclosed |
| EP-1179520-A1 | Process for the preparation of phytone and novel intermediates thereof | AVENTIS ANIMAL NUTRITION S.A. (FR) | 2002-02-13 | — | — | EP | disclosed |
| US-4169157-A | Therapeutic preparations for peptic ulcers comprising aliphatic ketone derivative | EISAI CO., LTD. (JP) | 1979-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249321-A1 | HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE y, -POSITION | VKORC1, VKORC1L1, CBR1 | KDM1A 839/4885ALOX15 412/4885ALDH1A1 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.